Showing results (41-50 of 216) with videos related to
Sort By:
Pageof 22
Respiration; International Review of Thoracic Diseases|January 1, 1975
Comparative measurements of airway resistanceH Matthys, U OrthPhytomedicine : International Journal of Phytotherapy and Phytopharmacology|December 23, 2006
EPs 7630-solution--an effective therapeutic option in acute and exacerbating bronchitisH Matthys, M HegerPneumologie (Stuttgart, Germany)|February 1, 1990
[Acute and long-term effects of chronic obstructive lung diseases]G Klein, H MatthysPneumologie (Stuttgart, Germany)|February 1, 1990
[Trans-tracheal long-term oxygen therapy in respiratory failure]G Würtemberger, H MatthysRespiration; International Review of Thoracic Diseases|January 1, 1981
Different therapies and factors influencing response to therapy in idiopathic diffuse fibrosing alveolitisU Costabel, H MatthysPathology, Research and Practice|January 1, 1982
Selective inhibition of human neutrophilic chemotaxis by echo virus, type 9. Virus-induced changes in membrane fluidityB Bültmann, I Melzner, O Haferkamp, et al.Zeitschrift Fur Gastroenterologie|October 1, 1981
[Sclerosing mesenteritis: case reports and review of literature (author's transl)]B Bültmann, P Merkle, G Walter, et al.MMW, Munchener Medizinische Wochenschrift|October 10, 1980
[Influenza A virus infection, a precipitating factor for the major heart attack (author's transl)]R Vüllers, B Bültmann, H Fischer, et al.Klinische Wochenschrift|August 15, 1975
[Granulocyte dysfunction. Part II. Secondary defects. (authors transl)]D Niethammer, A Wildfeuer, E Kleihauer, et al.The Journal of Infectious Diseases|February 1, 1977
Role of Candida albicans in granulomatous tissue reactions. I. In vitro degradation of C. albicans and immunospecificity of split productsH Meister, B Heymer, H Schäfer, et al.Pageof 22